| # | Drug | Count |
|---|---|---|
| 0 | OMALIZUMAB | 106 |
| 1 | CETIRIZINE HYDROCHLORIDE | 85 |
| 2 | CETIRIZINE | 66 |
| 3 | MONTELUKAST | 45 |
| 4 | PREDNISONE | 40 |
| 5 | MONTELUKAST SODIUM | 37 |
| 6 | CETIIRIZINE | 35 |
| 7 | CETIRIZINE HYDROCHLORIDE ALLERGY | 32 |
| 8 | CETIRIZINE HYDROCHLORIDE TABLETS | 32 |
| 9 | IBUPROFEN | 31 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ADRENAL SUPPORT | 1 | 0.0400 |
| 1 | OMALIZUMAB-IGEC | 2 | 0.0225 |
| 2 | DEXBROMPHENIRAMINE MALEATE, DEXTROMETHORPHAN HYDROBROMIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE | 1 | 0.0123 |
| 3 | DEXTRAN, HYPROMELLOSE | 1 | 0.0043 |
| 4 | FROVATRIPTAN SUCCINATE | 3 | 0.0038 |
| 5 | ORPHENADRINE CITRATE | 2 | 0.0032 |
| 6 | ADALIMUMAB-ATTO | 5 | 0.0031 |
| 7 | ANHYDROUS CITRIC ACID, ASPIRIN, AND SODIUM BICARBONATE | 1 | 0.0030 |
| 8 | REMIBRUTINIB | 4 | 0.0030 |
| 9 | PENICILLIN G BENZATHINE | 4 | 0.0029 |
| # | Drug class | Count |
|---|---|---|
| 0 | Anti-IgE [EPC] | 106 |
| 1 | Corticosteroid [EPC] | 79 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 67 |
| 3 | Benzodiazepine [EPC] | 39 |
| 4 | Histamine-1 Receptor Antagonist [EPC] | 39 |
| 5 | Angiotensin 2 Receptor Blocker [EPC] | 33 |
| 6 | Platelet Aggregation Inhibitor [EPC] | 24 |
| 7 | Proton Pump Inhibitor [EPC] | 24 |
| 8 | Progestin [EPC] | 23 |
| 9 | Histamine-2 Receptor Antagonist [EPC] | 22 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Anti-IgE [EPC] | 106 | 0.0012 |
| 1 | Gamma Secretase Inhibitor [EPC] | 1 | 0.0011 |
| 2 | Serotonin-1b and Serotonin-1d Receptor Agonist [EPC] | 15 | 0.0006 |
| 3 | Leukotriene Receptor Antagonist [EPC] | 14 | 0.0005 |
| 4 | Human Immunoglobulin G [EPC] | 10 | 0.0005 |
| 5 | Histamine-1 Receptor Antagonist [EPC] | 39 | 0.0005 |
| 6 | Plasma Volume Expander [EPC] | 1 | 0.0003 |
| 7 | Thyroid Hormone Synthesis Inhibitor [EPC] | 3 | 0.0003 |
| 8 | Allylamine Antifungal [EPC] | 2 | 0.0003 |
| 9 | Anti-coagulant [EPC] | 1 | 0.0003 |